Paris - Delayed Quote • EUR
MedinCell S.A. (MEDCL.PA)
At close: 5:35 PM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 4 | 2 |
| Avg. Estimate | 0 | 0 | -1.02 | 0.08 |
| Low Estimate | 0 | 0 | -1.22 | -0.48 |
| High Estimate | 0 | 0 | -0.82 | 0.64 |
| Year Ago EPS | -- | -- | -1.02 | -1.02 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 6 | 6 |
| Avg. Estimate | -- | -- | 14.78M | 50.13M |
| Low Estimate | -- | -- | 10.5M | 30M |
| High Estimate | -- | -- | 19.4M | 76M |
| Year Ago Sales | -- | -- | 9.89B | 14.78M |
| Sales Growth (year/est) | -- | -- | -99.90% | 239.20% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.02 | 0.08 |
| 7 Days Ago | 0 | 0 | -1.01 | -0.41 |
| 30 Days Ago | 0 | 0 | -1.01 | -0.41 |
| 60 Days Ago | 0 | 0 | -1.01 | -0.41 |
| 90 Days Ago | 0 | 0 | -1.01 | -0.22 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 2 |
| Up Last 30 Days | -- | -- | -- | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | MEDCL.PA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 0.40% |
| Next Qtr. | -- | -- | -- | 9.90% |
| Current Year | 0.00% | -- | -- | 4.30% |
| Next Year | 107.80% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Related Tickers
ADOC.PA Adocia SA
8.62
-0.69%
POXEL.PA Poxel S.A.
0.7700
-2.65%
NANO.PA Nanobiotix S.A.
5.75
+6.88%
ONWD.BR Onward Medical N.V.
5.06
+0.80%
ALOPM.PA Oncodesign Precision Medicine Société anonyme
1.5250
+1.67%
NBTX Nanobiotix S.A.
5.71
-0.35%
ALGEN.PA genOway Société anonyme
3.9400
+1.03%
ALACT.PA Acticor Biotech SAS
3.8900
+1.83%
SIGHT.PA GenSight Biologics S.A.
0.4070
-0.61%
ABVX.PA ABIVAX Société Anonyme
15.18
+5.42%